Texans may recognize the following brand names of GLP-1 weight loss drugs: Ozempic (semaglutide from Novo Nordisk) Rybelsus (semaglutide from Novo Nordisk) Wegovy (semaglutide from Novo Nordisk) Mounjaro (tirzepatide from Eli Lilly and Company) Zepbound (tirzepatide from Eli Lilly and Company) Saxenda (liraglutide from Novo Nordisk) Victoza (liraglutide from Novo Nordisk) Trulicity (dulaglutide from Eli Lilly and Company) Bursor & Fisher, P.A
These typically occur during early treatment as the body adjusts to the medication
One of the multiple theories explaining obesity focuses on the transition from high-fiber diets to energy-dense, palatable diets, with current knowledge derived mainly from animal studies and neuroimaging research (113, 119)
Erratum in: Diab Vasc Dis Res
Calcium, Vitamin D, and Protein: Key Nutrients for Bone and Muscle For individuals using GLP-1 medications for weight management, protecting bone health and mitigating muscle loss through diet and exercise is critical in order to avoid complications like osteoporosis and bone loss
However, the approval of GLP-1s has also led to health care professionals facing several barriers in prescribing the medications, including prior authorization requests, the need for dose adjustments and drug shortages
)
